Westfuller Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Sell
2,096
-67
-3% -$68.5K 0.92% 35
2026
Q1
$1.99M Sell
2,163
-124
-5% -$126K 0.86% 33
2025
Q4
$2.46M Sell
2,287
-36
-2% -$34.4K 0.99% 29
2025
Q3
$1.77M Buy
2,323
+732
+46% +$545K 0.81% 34
2025
Q2
$1.24M Buy
1,591
+1,274
+402% +$990K 0.71% 34
2025
Q1
$262K Buy
+317
New +$264K 0.17% 80

Other funds holding LLY

Westfuller Advisors's LLY Position: Q2 2026 in Review

Westfuller Advisors reduced its Eli Lilly (LLY) stake by 3.1% in Q2 2026, selling an estimated $68.5K and leaving 2,096 shares worth $2.51M. The position accounts for 0.92% of the portfolio, ranked #35.

Westfuller Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Westfuller Advisors held 2,096 shares of Eli Lilly worth $2.51M as of Q2 2026.
  • Westfuller Advisors sold 67 Eli Lilly shares in Q2 2026, an estimated $68.5K.
  • Eli Lilly made up 0.92% of Westfuller Advisors's portfolio in Q2 2026, its #35 holding.
  • Westfuller Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.